3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
6
Carcinoid Tumor
5
Neoplasms
4
Carcinoma
3
Vipoma
2
Neoplasm Metastasis
2
Intestinal Obstruction
2
Carcinoma, Islet Cell
2
Somatostatinoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Inoperable Thymoma
1
Pleural Effusion
1
Peritoneal Neoplasms
1
Malignant Carcinoid Syndrome
1
Lymphangiomyoma
1
Lymphangioleiomyomatosis
1
Insulinoma
1
Glucagonoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Gastrinoma
1
Diarrhea
1
Chylous Ascites
1
Chylothorax
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Ascites
1
Adenoma, Islet Cell
1
Interventions
Dexamethasone
17
Palonosetron
13
Aprepitant
13
Ondansetron
12
Calcium Dobesilate
12
Granisetron
7
dexamethasone acetate
5
Doxorubicin
5
Cyclophosphamide
4
fosaprepitant
3
dexamethasone 21-phosphate
3
Vincristine
3
Olanzapine
3
Cisplatin
3
Therapeutics
2
Sugars
2
Radiotherapy
2
Mesna
2
Lorazepam
2
Ifosfamide
2
Fluorouracil
2
Dronabinol
2
Diphenhydramine
2
rolapitant
1
netupitant
1
isatuximab
1
ginger extract
1
dolasetron
1
casopitant
1
auricularum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nausea
×
Octreotide
×
Clear all
No trials found.